Pharmacology II MD0805

Description

DEVELOPMENT TABLE OF CONTENTS ADMINISTRATION INTRODUCTION LESSON 1 Section I. BACKGROUND INFORMATION 1-1, DEFINITION OF DERMATOLOGICAL AGENTS 1-2, GENERAL CONSIDERATIONS INVOLVING DERMATOLOGICAL AGENTS Section II. THERAPEUTIC CATEGORIES OF DERMATOLOGICAL AGENTS 1-3, ANTISEBORRHEICS 1-4, ASTRINGENTS 1-5, KERATOLYTICS EXERCISES SOLUTIONS ANNEX LESSON 2 THE HUMAN MUSCULAR SYSTEM 2-1, BACKGROUND 2-2, TERMS ASSOCIATED WITH THE HUMAN MUSCULAR SYSTEM 2-3, PROPERTIES OF MUSCLE TISSUE 2-4, TYPES OF MUSCLE TISSUE EXERCISES SOLUTIONS ANNEX LESSON 3 Section 1, GENERAL 3-1, BACKGROUND 3-2, DEFINITION OF A MUSCLE RELAXANT Section II, THE NEUROMUSCULAR BLOCKING AGENTS 3-3, MECHANISM OF ACTION 3-4, USE OF THE NEUROMUSCULAR BLOCKING AGENTS 3-5, CLASSIFICATION OF THE NEUROMUSCULAR BLOCKING AGENTS Section III, CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS 3-6, BACKGROUND 3-7, EXAMPLES OF CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS EXERCISES SOLUTIONS ANNEX LESSON 4 Section 1, BACKGROUND 4-1, INTRODUCTION TO ANALGESIC, ANTI-INFLAMMATORY, AND ANTI-GOUT AGENTS 4-2, DEFINITIONS Section II, ANALGESIC AGENTS 4-3, BACKGROUND 4-4, SPECIFIC ANALGESIC AGENTS Section III, ANTI-INFLAMMATORY AGENTS 4-5, BACKGROUND 4-6, SPECIFIC ANTI-INFLAMMATORY AGENTS Section IV. ANTIGOUT AGENTS 4-7, BACKGROUND 4-8, DRUGS USED TO TREAT GOUT EXERCISES SOLUTIONS ANNEX LESSON 5 Section 1, OCCULAR ANATOMY AND PHYSIOLOGY 5-1, BACKGROUND 5-2, THE BULBUS OCULI 5-3, THE ADNEXA 5-4, DISEASES/CONDITIONS AFFECTING THE EYE Section II, AUDITORY ANATOMY AND PHYSIOLOGY 5-5, BACKGROUND 5-6, THE EXTERNAL EAR 5-7, THE MIDDLE EAR 5-8, THE INTERNAL EAR 5-9, DISORDERS OR MALFUNCTIONS OF THE EAR Section III, ANATOMY AND PHYSIOLOGY OF EQUILIBRIUM (BALANCE) 5-10, BACKGROUND 5-11, SACCULUS AND UTRICULUS 5-12, SEMICIRCULAR DUCTS 5-13, THE VESTIBULAR NERVE EXERCISES SOLUTIONS ANNEX LESSON 6 INTRODUCTION BACKGROUND REVIEW OF THE HUMAN NERVOUS SYSTEM THE AUTONOMIC NERVOUS SYSTEM INTRODUCTION CONTROL OF THE AUTONOMIC NERVOUS SYSTEM ORGANIZATION OF THE AUTONOMIC NERVOUS SYSTEM THE SYMPATHETIC NERVOUS SYSTEM INTRODUCTION TO THE SYMPATHETIC NERVOUS SYSTEM PHYSIOLOGY OF THE SYMPATHETIC NERVOUS SYSTEM ALPHA AND BETA RECEPTOR SITES EFFECTS PRODUCED BY THE SYMPATHETIC NERVOUS SYSTEM THE PARASYMPATHETIC NERVOUS SYSTEM INTRODUCTION TO THE PARASYMPATHETIC NERVOUS SYSTEM PHYSIOLOGY OF THE PARASYMPATHETIC NERVOUS SYSTEM EFFECTS PRODUCED BY THE PARASYMPATHETIC NERVOUS SYSTEM EXERCISES SOLUTIONS ANNEX LESSON 7 ADRENERGIC AGENTS 7-1, BACKGROUND 7-2, MECHANISMS OF ACTION OF AGENTS WHICH STIMULATE SYMPATHETIC NERVOUS SYSTEM 7-3, RECEPTOR SITE THEORY OF ADRENERGIC TRANSMISSION 7-4, PHARMACOLOGICAL EFFECTS PRODUCED BY ADRENERGIC STIMULATION 7-5, ADRENERGIC (SYMPATHOHIMETIC) DRUGS 7-6, SPECIFIC ADRENERGIC (SYMPATHOMIMETIC) AGENTS EXERCISES SOLUTIONS ANNEX LESSON 8 ADRENERGIC BLOCKING AGENTS 8-1, INTRODUCTION TO ADRENERGIC BLOCKING AGENTS 8-2, GENERAL MECHANISMS OF ACTION OF ADRENERGIC BLOCKING AGENTS 8-3, PRINCIPAL TYPES OF ADRENERGIC RECEPTORS 8-4, ALPHA ADRENERGIC BLOCKING AGENTS 8-5, BETA-ADRENERGIC BLOCKING AGENTS EXERCISES SOLUTIONS ANNEX LESSON 9 CHOLINERGIC AGENTS 9-1, INTRODUCTION 9-2, REVIEW OF THE PHYSIOLOGY OF THE CHOLINERGIC PARASYMPATHETIC) NERVOUS SYSTEM 9-3, CHEMICAL TRANSMISSION IN THE CHOLINERGIC (PARASYMPATHETIC) NERVOUS SYSTEM 9-4, EFFECTS PRODUCED BY THE CHOLINERGIC NERVOUS SYSTEM 9-5, THERAPEUTIC USE OF CHOLINERGIC AGENTS 9-6, TYPES OF CHOLINERGIC AGENTS EXERCISES SOLUTIONS ANNEX LESSON 10 CHOLINERGIC BLOCKING AGENTS (ANTICHOLINERGIC AGENTS) 10-1, INTRODUCTION 10-2, PHARMACOLOGICAL EFFECTS OF THE CHOLINERGIC BLOCKERS 10-3, CLINICAL USES OF THE CHOLINERGIC BLOCKERS 10-4, EXAMPLES OF CHOLINERGIC BLOCKING AGENTS EXERCISES SOLUTIONS ANNEX